The search results were uploaded into an Internet-based management program (Systematic Review System). Two members of the research team independently screened the citations (title and abstract).

CCR5 antagonists show promise for stroke cerebroprotection and recovery, although further preclinical evidence in clinically relevant domains could strengthen support for clinical translation.